ASP2151 + Valacyclovir + Placebo

Phase 1Terminated
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety of ASP2151

Conditions

Safety of ASP2151

Trial Timeline

Mar 1, 2009 โ†’ Apr 1, 2010

About ASP2151 + Valacyclovir + Placebo

ASP2151 + Valacyclovir + Placebo is a phase 1 stage product being developed by Astellas Pharma for Safety of ASP2151. The current trial status is terminated. This product is registered under clinical trial identifier NCT00870441. Target conditions include Safety of ASP2151.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT00870441Phase 1Terminated
NCT00486200Phase 2Completed